|
| | Publication Year | Title | Author(s) |
| 421 | Aug-2023 | Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy. | Wang, Yang; Mathai, Jared; Alamgeer, Muhammad; Parakh, Sagun ; Paul, Eldho; Mitchell, Paul L R ; Arulananda, Surein |
| 422 | 31-Jul-2023 | Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. | Poh, Ashleigh; Sammour, Abdelaziz; Mathai, Jared; Peverall, Joanne; Van Vliet, Chris; Asadi, Khashayar ; Parakh, Sagun |
| 423 | 2023 | Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter? | Pereira-Salgado, Amanda; Anton, Angelyn; Franchini, Fanny; Mahar, Robert K; Kwan, Edmond M; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun A; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Steer, Christopher; Brown, Stephen; Gibbs, Peter; Tran, Ben; IJzerman, Maarten |
| 424 | Feb-2019 | Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. | Parakh, Sagun ; Randhawa, Manreet; Nguyen, Bella; Warburton, Lydia; Hussain, Mohammad Akhtar; Cebon, Jonathan S ; Millward, Michael; Yip, Desmond; Ali, Sayed |
| 425 | 14-Dec-2021 | Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer. | Anton, Angelyn; Pillai, Sruti; Semira, Marie Christine; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Baenziger, Olivia; Gibbs, Peter; Tran, Ben |
| 426 | Dec-2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer. | Conduit, C; de Boer, R H; Lok, S; Gibbs, P; Malik, L; Loh, Zoe ; Yeo, Belinda ; Greenberg, S; Devitt, B; Lombard, J; Nottage, M; Collins, I; Torres, J; Nolan, M; Nott, L |
| 427 | 31-Jul-2021 | Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study. | Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Semira, Marie C; Gibbs, Peter; Tran, Ben; Pezaro, Carmel |
| 428 | 14-Jul-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study. | Tung, Iris; Moldovan, Cristina; Wong, Vanessa ; De Boer, Richard; Yeo, Belinda ; Malik, Laeeq; Greenberg, Sally; Anton, Angelyn; Nott, Louise; Barnett, Frances; Collins, Ian M; Lombard, Janine; Nottage, Michelle; Sahu, Arvind; Torres, Javier; Gibbs, Peter; Lok, Sheau Wen |
| 429 | 30-Aug-2022 | Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer. | Wong, Vanessa ; de Boer, Richard; Baron-Hay, Sally; Blum, Robert; Boyle, Frances; Chua, Susan; Clarke, Kerrie; Cuff, Katharine; Green, Michael; Lim, Elgene; Mok, Kelly; Nott, Louise; Nottage, Michelle; Tafreshi, Ali; Tsoi, Daphne; Uccellini, Anthony; Hong, Wei; Gibbs, Peter; Lok, Sheau Wen |
| 430 | 15-Nov-2021 | Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists. | Xing, Daniel T ; Khor, Richard ; Gan, Hui K ; Wada, Morikatsu ; Ermongkonchai, Tai; Ng, Sweet Ping |
| 431 | 8-Mar-2018 | Receptor Occupancy Imaging Studies in Oncology Drug Development. | Burvenich, Ingrid J G; Parakh, Sagun ; Parslow, Adam C; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M |
| 432 | 30-Jan-2020 | Rectal Bleeding | Burgess, Adele N |
| 433 | Feb-2016 | Recurrent glioblastoma: current patterns of care in an Australian population | Parakh, Sagun ; Thursfield, Vicky; Cher, Lawrence M ; Dally, Michael; Drummond, Katharine J; Murphy, Michael; Rosenthal, Mark A; Gan, Hui K |
| 434 | Sep-2017 | Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase. | Do, Hongdo; Molania, Ramyar; Mitchell, Paul L R ; Vaiskunaite, Rita; Murdoch, John D; Dobrovic, Alexander |
| 435 | 10-Aug-2016 | Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): a multinational placebo-controlled phase II tria | Pavlakis, Nick; Sjoquist, Katrin M; Martin, Andrew J; Tsobanis, Eric; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Alcindor, Thierry; O’Callaghan, Christopher J; Burnell, Margot J; Tebbutt, Niall C ; Rha, Sun Young; Lee, Jeeyun; Cho, Jae-Yong; Lipton, Lara R; Wong, Mark; Strickland, Andrew; Kim, Jin Won; Zalcberg, John R; Simes, John; Goldstein, David |
| 436 | 21-Sep-2023 | Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity. | Marwah, Ravi; Xing, Daniel T ; Squire, Timothy; Soon, Yu Yang; Gan, Hui K ; Ng, Sweet Ping |
| 437 | 2021 | Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer. | Heynemann, Sarah; Mitchell, Paul |
| 438 | 11-Apr-2017 | Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''. | Bowyer, Samantha; Prithviraj, Prashanth; Lorigan, Paul; Larkin, James; McArthur, Grant; Atkinson, Victoria; Millward, Michael; Khou, Muoi; Diem, Stefan; Ramanujam, Sangeetha; Kong, Ben; Liniker, Elizabeth; Guminski, Alexander; Parente, Phillip; Andrews, Miles C; Parakh, Sagun ; Cebon, Jonathan S ; Long, Georgina V; Carlino, Matteo S; Klein, Oliver |
| 439 | Apr-2020 | Reply to the letter-to-the editor "Hospital volume and the case for centralisation of surgical services". | Thai, Alesha A; Stuart, E; Te Marvelde, L; Milne, R L; Knight, Simon R ; Whitfield, K; Mitchell, Paul L R |
| 440 | Jan-2016 | The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members | Maillet, D; Blay, JY; You, B; Rachdi, A; Gan, Hui K ; Péron, Julien |
